2022 Saudi Guideline for Chronic Kidney Disease: Blood Pressure Management and Kidney Replacement Therapy in Adults and Children
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Authors:
Saudi CKD Group
Willingness to Collaborate :
No
English Title Translation:
Keywords:
chronic kidney disease; clinical practice guideline; blood pressure measurement; antihypertensive agents; kidney replacement therapy
MeSH Terms:
Renal Insufficiency (C12.050.351.968.419.780);
Renal Dialysis (E02.870.300, E02.912.800) ; Kidney Diseases (C12.050.351.968.419);
Renal Insufficiency, Chronic (C12.050.351.968.419.780.750);
Middle East (Z01.252.245.500); Saudi Arabia (Z01.252.245.500.750); Antihypertensive Agents (D27.505.954.411.162);
Angiotensin-Converting Enzyme Inhibitors (D27.505.519.389.745.085); Angiotensin Receptor Antagonists (D27.505.519.162); Adrenergic beta-Antagonists )D27.505.519.625.050.200.200); Adrenergic alpha-Antagonists (D27.505.519.625.050.200.100); Diuretics (D27.505.696.560.500); Calcium Channel Blockers (D27.505.519.562.249); Renal Replacement Therapy (E02.870); Attitude to Health (F01.100.150, N05.300.150); Hypertension, Renal (C12.050.351.968.419.331)
Collection:
guidelines international network
Publication Scope:
assessment
counselling
management
Patient education
treatment
Countries of Application:
Kingdom of Saudi Arabia
Guideline Publication Status :
Development
Languages :
English
Expected Publication Date:
29/04/2022
Date of Last Evidence Search:
10/01/2021
Methods Applied:
GRADE-ADOLOPMENT; AGREE II; Systematic review; Risk of Bias; GRADE